nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—Ephedrine—SLC18A2—type 1 diabetes mellitus	0.02	0.288	CrCbGaD
Etomidate—Pseudoephedrine—IL2—type 1 diabetes mellitus	0.0173	0.249	CrCbGaD
Etomidate—Tropicamide—CHRM2—type 1 diabetes mellitus	0.0141	0.203	CrCbGaD
Etomidate—Pseudoephedrine—ADRB1—type 1 diabetes mellitus	0.00616	0.0887	CrCbGaD
Etomidate—Pseudoephedrine—TNF—type 1 diabetes mellitus	0.00584	0.0842	CrCbGaD
Etomidate—Fenoprofen—ALB—type 1 diabetes mellitus	0.0034	0.0489	CrCbGaD
Etomidate—SLC2A1—Metabolism—HBA2—type 1 diabetes mellitus	0.00272	0.00292	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00272	0.00292	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00265	0.00285	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00265	0.00285	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00263	0.00282	CbGpPWpGaD
Etomidate—Pethidine—ALB—type 1 diabetes mellitus	0.00256	0.0369	CrCbGaD
Etomidate—SLC2A1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00256	0.00275	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00251	0.0027	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00248	0.00267	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00243	0.00261	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00243	0.00261	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00242	0.0026	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.0024	0.00258	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SIRPG—type 1 diabetes mellitus	0.0024	0.00258	CbGpPWpGaD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00234	0.00252	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—GAD2—type 1 diabetes mellitus	0.00232	0.00249	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—NOS3—type 1 diabetes mellitus	0.00232	0.00249	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00222	0.00238	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00217	0.00233	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—GAD2—type 1 diabetes mellitus	0.00212	0.00228	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00212	0.00228	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00212	0.00228	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.0021	0.00226	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.0021	0.00225	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00203	0.00218	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00203	0.00218	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—GAD1—type 1 diabetes mellitus	0.00201	0.00216	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP3—type 1 diabetes mellitus	0.00197	0.00211	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—IL2—type 1 diabetes mellitus	0.00197	0.00211	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00192	0.00206	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00186	0.002	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00186	0.002	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—GAD2—type 1 diabetes mellitus	0.00185	0.00199	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00185	0.00199	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SLC11A1—type 1 diabetes mellitus	0.00185	0.00199	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—GAD1—type 1 diabetes mellitus	0.00184	0.00198	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.00184	0.00198	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ITPR3—type 1 diabetes mellitus	0.00177	0.0019	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00175	0.00188	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00173	0.00186	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00168	0.0018	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOC3—type 1 diabetes mellitus	0.00165	0.00177	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IAPP—type 1 diabetes mellitus	0.00165	0.00177	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00165	0.00177	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—ITPR3—type 1 diabetes mellitus	0.00163	0.00175	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00162	0.00175	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00162	0.00174	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—GAD1—type 1 diabetes mellitus	0.00161	0.00173	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00161	0.00172	CbGpPWpGaD
Etomidate—SLC2A1—Disease—B2M—type 1 diabetes mellitus	0.00158	0.0017	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00151	0.00162	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00148	0.00159	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ITPR3—type 1 diabetes mellitus	0.00148	0.00159	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00146	0.00157	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00146	0.00157	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00143	0.00153	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HBA2—type 1 diabetes mellitus	0.00142	0.00153	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.0014	0.0015	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HBA1—type 1 diabetes mellitus	0.00139	0.0015	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00139	0.00149	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOC3—type 1 diabetes mellitus	0.00138	0.00149	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00138	0.00148	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTT1—type 1 diabetes mellitus	0.00136	0.00146	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—G6PC2—type 1 diabetes mellitus	0.00134	0.00144	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS1—type 1 diabetes mellitus	0.00133	0.00143	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00132	0.00142	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00132	0.00141	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00131	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00128	0.00137	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PRKCQ—type 1 diabetes mellitus	0.00124	0.00134	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HBA2—type 1 diabetes mellitus	0.00122	0.00132	CbGpPWpGaD
Etomidate—SLC2A1—Disease—VAV1—type 1 diabetes mellitus	0.00121	0.0013	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.00119	0.00128	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00118	0.00127	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCC8—type 1 diabetes mellitus	0.00116	0.00125	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00115	0.00124	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	0.00115	0.00123	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00114	0.00123	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00113	0.00122	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00113	0.00121	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	0.00112	0.0012	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00111	0.0012	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00111	0.0012	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00109	0.00117	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GCG—type 1 diabetes mellitus	0.00108	0.00116	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SELL—type 1 diabetes mellitus	0.00107	0.00115	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00106	0.00114	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD86—type 1 diabetes mellitus	0.00105	0.00113	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00105	0.00113	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00101	0.00109	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	0.00101	0.00109	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00101	0.00108	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00101	0.00108	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000999	0.00107	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000999	0.00107	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000997	0.00107	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB3—type 1 diabetes mellitus	0.00095	0.00102	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CCR5—type 1 diabetes mellitus	0.000934	0.001	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00092	0.000988	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000916	0.000984	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CAT—type 1 diabetes mellitus	0.000916	0.000984	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000912	0.00098	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HLA-A—type 1 diabetes mellitus	0.00091	0.000978	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000879	0.000945	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000874	0.000939	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	0.000851	0.000914	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000842	0.000905	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITPR3—type 1 diabetes mellitus	0.000841	0.000903	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.000822	0.000883	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000804	0.000864	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000797	0.000857	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000793	0.000852	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS2—type 1 diabetes mellitus	0.000792	0.000851	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SH2B3—type 1 diabetes mellitus	0.000791	0.00085	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000789	0.000848	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000773	0.000831	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000772	0.00083	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000769	0.000826	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD80—type 1 diabetes mellitus	0.000768	0.000826	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000763	0.000819	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.00075	0.000806	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HBA1—type 1 diabetes mellitus	0.000728	0.000782	CbGpPWpGaD
Etomidate—SLC2A1—Disease—INS—type 1 diabetes mellitus	0.000726	0.00078	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOC3—type 1 diabetes mellitus	0.000723	0.000777	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—type 1 diabetes mellitus	0.00071	0.000763	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HBA2—type 1 diabetes mellitus	0.000694	0.000746	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000692	0.000743	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.00069	0.000742	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000688	0.000739	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000666	0.000716	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000655	0.000703	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000653	0.000702	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000653	0.000701	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	0.000649	0.000697	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TYK2—type 1 diabetes mellitus	0.000649	0.000697	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000642	0.000689	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—type 1 diabetes mellitus	0.000637	0.000684	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000637	0.000684	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS1—type 1 diabetes mellitus	0.000633	0.00068	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000629	0.000676	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HBA1—type 1 diabetes mellitus	0.000627	0.000674	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOC3—type 1 diabetes mellitus	0.000623	0.00067	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	0.000615	0.000661	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000612	0.000658	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—INS—type 1 diabetes mellitus	0.000608	0.000653	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.000592	0.000637	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000592	0.000636	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD4—type 1 diabetes mellitus	0.000587	0.00063	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000578	0.000621	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VAV1—type 1 diabetes mellitus	0.000575	0.000618	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000573	0.000616	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000572	0.000614	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000572	0.000614	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000566	0.000608	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GCG—type 1 diabetes mellitus	0.000566	0.000608	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000564	0.000606	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALB—type 1 diabetes mellitus	0.000557	0.000599	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000537	0.000578	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—type 1 diabetes mellitus	0.000533	0.000573	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000531	0.000571	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—type 1 diabetes mellitus	0.000521	0.00056	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000502	0.000539	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000499	0.000536	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000498	0.000535	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000497	0.000534	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GCG—type 1 diabetes mellitus	0.000488	0.000524	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000483	0.000518	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAT—type 1 diabetes mellitus	0.000479	0.000515	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—type 1 diabetes mellitus	0.000454	0.000488	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000451	0.000485	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000447	0.000481	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000438	0.000471	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000436	0.000469	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000434	0.000467	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAT—type 1 diabetes mellitus	0.000413	0.000444	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—type 1 diabetes mellitus	0.000413	0.000444	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000405	0.000435	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000396	0.000426	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000394	0.000424	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000389	0.000418	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000378	0.000406	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—type 1 diabetes mellitus	0.000377	0.000405	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000374	0.000402	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000364	0.000391	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000363	0.00039	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000359	0.000386	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HBA1—type 1 diabetes mellitus	0.000355	0.000382	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOC3—type 1 diabetes mellitus	0.000353	0.00038	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000353	0.000379	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000347	0.000373	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000342	0.000367	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00034	0.000365	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000338	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000338	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—type 1 diabetes mellitus	0.000334	0.000359	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00033	0.000355	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000329	0.000354	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000328	0.000353	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.00032	0.000344	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INS—type 1 diabetes mellitus	0.000318	0.000342	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000317	0.000341	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—type 1 diabetes mellitus	0.000317	0.000341	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—type 1 diabetes mellitus	0.000317	0.000341	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—type 1 diabetes mellitus	0.000303	0.000326	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—type 1 diabetes mellitus	0.000292	0.000313	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000287	0.000308	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000285	0.000306	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000281	0.000302	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—type 1 diabetes mellitus	0.000279	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000277	0.000298	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCG—type 1 diabetes mellitus	0.000276	0.000297	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—type 1 diabetes mellitus	0.000274	0.000294	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000268	0.000288	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000267	0.000286	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000267	0.000286	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—type 1 diabetes mellitus	0.000257	0.000276	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000255	0.000274	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000252	0.00027	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—type 1 diabetes mellitus	0.000251	0.00027	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—type 1 diabetes mellitus	0.00024	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000234	0.000252	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAT—type 1 diabetes mellitus	0.000234	0.000251	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000233	0.00025	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000209	0.000224	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000201	0.000216	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000195	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000194	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000177	0.000191	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000177	0.00019	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00017	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000162	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000161	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—type 1 diabetes mellitus	0.000155	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000153	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000151	0.000162	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000149	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000148	0.000159	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—type 1 diabetes mellitus	0.000142	0.000153	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—type 1 diabetes mellitus	0.000136	0.000146	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000124	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000117	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000113	0.000122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000113	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000105	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000103	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.73e-05	9.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	8.71e-05	9.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.67e-05	9.32e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.33e-05	7.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.67e-05	7.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.12e-05	5.5e-05	CbGpPWpGaD
